| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Mouse |
| Host species | Goat |
| Applications | ELISA,IHC-Fr |
| Brand: | Abnova |
| Reference: | PAB7542 |
| Product name: | DIO2 polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of DIO2. |
| Gene id: | 1734 |
| Gene name: | DIO2 |
| Gene alias: | 5DII|D2|SelY|TXDI2 |
| Gene description: | deiodinase, iodothyronine, type II |
| Immunogen: | A synthetic peptide corresponding to human DIO2. |
| Immunogen sequence/protein sequence: | EVKKHQNQEDRC |
| Protein accession: | NP_000784.2;NP_054644.1;NP_001007024.1 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:128000) Immunohistochemistry (Frozen sections) (2-3 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Specificity: | This antibody is expected to recognize both reported isoform a (NP_000784.2 and NP_054644.1) and isoform b (NP_001007024.1). |
| Reactivity: | Mouse |
| Application image: | ![]() |
| Application image note: | DIO2 polyclonal antibody (Cat # PAB7542, 2 ug/mL) staining of PFA-fixed cryo-sectioned mouse hippocampus. Microwaved antigen retrieval with citrate buffer pH 4.5, HRP-staining. |
| Applications: | ELISA,IHC-Fr |
| Shipping condition: | Dry Ice |
| Publications: | Ala92 type 2 deiodinase allele increases risk for the development of hypertension.Gumieniak O, Perlstein TS, Williams JS, Hopkins PN, Brown NJ, Raby BA, Williams GH. Hypertension. 2007 Mar;49(3):461-6. Epub 2007 Jan 15. |